Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 13,256 shares at $104.74 ($1.4M) on 2026-02-04, disclosed to the SEC on 2026-02-06.
Seasonal sale ($1.4M) by Chief Financial Officer — this insider has traded RYTM in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.74 | 1,500 | $157K | 11.2% |
| 2 | $104.74 | 1,500 | $157K | 11.2% |
| 3 | $106.60 | 1,000 | $107K | 7.6% |
| 4 | $106.60 | 1,000 | $107K | 7.6% |
| 5 | $107.67 | 747 | $80K | 5.7% |
| 6 | $107.67 | 747 |
| $80K |
| 5.7% |
| 7 | $106.06 | 3,381 | $359K | 25.5% |
| 8 | $106.06 | 3,381 | $359K | 25.5% |
| Total | $106.03 avg | 13,256 | $1.4M | 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |
| RYTM | SELL | 2025-07-11 | $4.8M | — | Filing → |